Its currently approved by the FDA to treat Barth syndrome, a rare, mitochondrial disease that can lead to an enlarged and weakened heart
And that means putting themselves at exceptional risk. What Is the FDA Reviewing at the July 2026 Peptide Meeting
International journal of molecular sciences , 26 (6), 2691
Eur J Pharmacol 781:8391 Staresinic M, Petrovic I, Novinscak T, Jukic I, Pevec D, Suknaic S, Kokic N, Batelja L, Brcic L, Boban-Blagaic A (2006) Effective therapy of transected quadriceps muscle in rat: gastric pentadecapeptide BPC 157
It has shown potential for supporting the management of chronic gastrointestinal conditions, such as inflammatory bowel diseases (IBD), including ulcerative colitis (UC)
2780 Richville Drive SE, Massillon, OH 44646 Questions